latam therapeutic drug monitoring tdm market
This unique report from provides information and analysis not available from any other published source.
The report is available by country, section, and can be customized to specific information needs and budget.
This new report from provides a comprehensive analysis of the Latin America therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays:
Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This unique market and technology assessment is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Competitive Assessments
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Fujifilm Wako
- Fujirebio
- Grifols
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- Mindray
- Quest Diagnostics
- QuidelOrtho
- Roche
- Siemens Healthineers
- Sysmex
- Thermo Fisher
- Tosoh
Introduction
Worldw ide Market and Technology Overview
A. Major Therapeutic Drug Monitoring Tests
The report provides segment test volume and sales forecasts for the following tests:
Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran,
Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium,
Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban,
Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin
and Warfarin.
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC
analyzers manufactured by Abaxis, Abbott, Alfa
W assermann, AMS, Awareness Technologies, Beckman
Coulter, Binding Site, bioMerieux, Carolina Chemistries,
DiaSorin, Grifols, Horiba, Medica, Nova Biomedical,
Ortho-Clinical Diagnostics, Polymedco, Randox, Roche,
Siemens Healthineers, Tosoh, Vital Diagnostics and
other suppliers.
C. Major In Vitro Diagnostic Technologies
And Their Potential
Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujifilm Wako
Fujirebio
Grifols
IL/Werfen
Kyowa Medex
PerkinElmer
Quest Diagnostics
QuidelOrtho
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
LatAm Anemia Diagnostic Testing Market Assessment
2023 LatAm Anemia Diagnostic Testing Market Assessment in 22 Countries--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities This unique report from
USD 7500 View Report2024 LATAM 22-Country Diagnostics Market for 500 Tests: Blood Banking, Cancer, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM--Competition, Opportunities
This new report provides granular analysis of the Latin America diagnostic testing market, including:Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica,
USD 24500 View Report2024 US Therapeutic Drug Monitoring (TDM) Market
2024 US Therapeutic Drug Monitoring (TDM) Market for 28 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for SuppliersThis new 249-page
USD 2450 View Report2024 UK Therapeutic Drug Monitoring (TDM) Market
2024 UK Therapeutic Drug Monitoring (TDM) Market for 28 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for SuppliersThis new 247-page
USD 2450 View ReportFill The Form For Sample Request